Suppr超能文献

成纤维细胞生长因子 21 对人体骨骼肌葡萄糖摄取的直接作用:对 2 型糖尿病和肥胖的影响。

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

机构信息

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Diabetes Metab Res Rev. 2011 Mar;27(3):286-97. doi: 10.1002/dmrr.1177.

Abstract

BACKGROUND

Fibroblast growth factor (FGF) 21, a novel member of the FGF family, plays a role in a variety of endocrine functions, including regulation of glucose and lipid metabolism. The role of FGF21 in skeletal muscle is currently not known.

METHODS

Serum levels and skeletal muscle mRNA of FGF21 were determined in normal glucose tolerant (n = 40) and type 2 diabetic (T2D; n = 40) subjects. We determined whether FGF21 has direct effects on glucose metabolism in cultured myotubes (n = 8) and extensor digitorum longus skeletal muscle.

RESULTS

Serum FGF21 levels increased 20% in T2D versus normal glucose tolerant subjects (p < 0.05), whereas skeletal muscle mRNA expression was unaltered. Fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), waist circumference, and body mass index (BMI) significantly correlated with serum FGF21 levels in T2D (p < 0.01), but not in normal glucose tolerant subjects. Serum FGF21 concentrations were greater in T2D patients in the highest tertile of fasting insulin (p < 0.05) and BMI (p < 0.05). Stepwise regression analysis identified BMI as the strongest independent variable correlating with FGF21. FGF21 exposure increased basal and insulin-stimulated glucose uptake in human myotubes, coincident with increased glucose transporter 1 mRNA, and enhanced glucose transporter 1 abundance at the plasma membrane. In isolated extensor digitorum longus muscle, FGF21 potentiated insulin-stimulated glucose transport, without altering phosphorylation of Akt or AMP-activated protein kinase.

CONCLUSIONS

Plasma FGF21 is increased in T2D patients, and positively correlated with fasting insulin and BMI. However, FGF21 has direct effects in enhancing skeletal muscle glucose uptake, providing additional points of regulation that may contribute to the beneficial effects of FGF21 on glucose homeostasis. Whether increased plasma FGF21 in T2D is a compensatory mechanism to increase glucose metabolism remains to be determined.

摘要

背景

成纤维细胞生长因子 21(FGF21)是成纤维细胞生长因子家族的一个新成员,在多种内分泌功能中发挥作用,包括调节葡萄糖和脂质代谢。FGF21 在骨骼肌中的作用目前尚不清楚。

方法

在正常糖耐量(n = 40)和 2 型糖尿病(T2D;n = 40)患者中测定血清 FGF21 水平和骨骼肌 mRNA。我们在培养的肌管(n = 8)和伸趾长肌骨骼肌中确定 FGF21 是否具有直接的葡萄糖代谢作用。

结果

T2D 患者的血清 FGF21 水平比正常糖耐量组升高 20%(p < 0.05),而骨骼肌 mRNA 表达无变化。空腹胰岛素、稳态模型评估的胰岛素抵抗(HOMA-IR)、腰围和体重指数(BMI)与 T2D 患者的血清 FGF21 水平显著相关(p < 0.01),但在正常糖耐量组中则不然。在空腹胰岛素最高三分位(p < 0.05)和 BMI 最高三分位(p < 0.05)的 T2D 患者中,血清 FGF21 浓度更高。逐步回归分析发现 BMI 是与 FGF21 相关性最强的独立变量。FGF21 暴露增加了人肌管的基础和胰岛素刺激的葡萄糖摄取,同时增加了葡萄糖转运蛋白 1 mRNA,并增强了质膜上的葡萄糖转运蛋白 1 丰度。在分离的伸趾长肌中,FGF21 增强了胰岛素刺激的葡萄糖转运,而不改变 Akt 或 AMP 激活蛋白激酶的磷酸化。

结论

T2D 患者的血浆 FGF21 增加,并与空腹胰岛素和 BMI 呈正相关。然而,FGF21 具有增强骨骼肌葡萄糖摄取的直接作用,提供了可能有助于 FGF21 对葡萄糖稳态有益影响的额外调节点。T2D 中增加的血浆 FGF21 是否是增加葡萄糖代谢的补偿机制仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验